Scarica l'app Stockscreener
8.57
14.30%
-1.43
Dopo l'orario di chiusura:
8.60
0.03
+0.35%
Precedente Chiudi:
$10.00
Aprire:
$8.55
Volume 24 ore:
56.76M
Relative Volume:
3.31
Capitalizzazione di mercato:
$37.69B
Reddito:
$14.54B
Utile/perdita netta:
$2.22B
Rapporto P/E:
17.59
EPS:
0.4871
Flusso di cassa netto:
$2.58B
1 W Prestazione:
-17.36%
1M Prestazione:
-5.51%
6M Prestazione:
-7.85%
1 anno Prestazione:
-5.30%
Intervallo 1D:
$8.38
$8.75
Intervallo di 1 settimana:
$8.38
$10.34
Portata 52W:
$8.38
$11.28
Haleon Plc Adr Stock (HLN) Company Profile
Compare HLN vs TAK, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLN
Haleon Plc Adr
|
8.57 | 37.69B | 14.54B | 2.22B | 2.58B | 0.4871 |
TAK
Takeda Pharmaceutical Co Adr
|
20.01 | 63.92B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.47 | 48.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.80 | 32.56B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
593.54 | 25.46B | 3.17B | 1.29B | 1.01B | 27.09 |
Haleon Plc Adr Stock (HLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-23 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-09-16 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-09-10 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-05-27 | Aggiornamento | BNP Paribas Exane | Neutral → Outperform |
| 2025-05-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-05 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-01-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-08-06 | Iniziato | Berenberg | Buy |
| 2024-08-06 | Downgrade | Goldman | Buy → Neutral |
| 2024-06-05 | Iniziato | Berenberg | Buy |
| 2024-04-17 | Iniziato | HSBC Securities | Buy |
| 2023-12-11 | Ripresa | Jefferies | Buy |
| 2023-11-01 | Iniziato | Morgan Stanley | Overweight |
| 2023-05-24 | Iniziato | Stifel | Hold |
| 2023-04-06 | Aggiornamento | Argus | Hold → Buy |
| 2023-04-04 | Iniziato | Bernstein | Outperform |
| 2022-12-07 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-09-28 | Iniziato | Argus | Hold |
Mostra tutto
Haleon Plc Adr Borsa (HLN) Ultime notizie
ASAIY or HLN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Haleon Launches ‘Haleon Health House,’ a One-Day Interactive Wellness Pop-Up in Toronto - GlobeNewswire Inc.
Prediction: These 3 Dividend Stocks Will Raise Their Payouts No Matter What the Market Does - The Motley Fool
Haleon (HLN) Stock Alert: -1.53% Breakdown Below $8.58 2026-09-29Jurik MA - https://www.dars.gov.et/
Haleon (HLN) Stock Alert: -1.53% Breakdown Below $8.58 2026-09-29Last Point Support - https://www.siam.in/
SGIOY Stock Price, Quote & News - Syfe
Haleon stock edges lower as half-year 2026 earnings growth supports valuation - ad-hoc-news.de
LCUT or HLN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Haleon stock gains visibility as Walmart shelf deal and analyst hold view shape sentiment - AD HOC NEWS
Haleon Targets Sensitive-Tooth Growth With New 8-Week Toothpaste Study - TipRanks
Games Workshop (LSE:GAW), Diageo (LSE:DGE) And Haleon (LSE:HLN) Test The Strength Of UK Consumer Brands - Kalkine Media
Starbucks Upgraded, Ralph Lauren Downgraded: Updated Rankings on Top Blue-Chip Stocks - investorplace.com
What Changed For Haleon While Big Pharma Slid Before The Long Weekend? - Kalkine Media
BNTX Stock Price, Quote & News - Syfe
Can Haleon (LSE:HLN) Margin Gains Offset Respiratory Weakness? - Kalkine Media
Haleon (HLN) Watch: Finishes 1.32% Up at $10.00 in the Latest Session; Range View: Support at $9.50 and Resistance at $10.50 Frame the Range under the Current SnapshotBear Pennant - careplusvn.com
Haleon (HLN) Watch: Finishes 1.32% Up at $10.00 in the Latest Session; Range View: Support at $9.50 and Resistance at $10.50 Frame the Range under the Current SnapshotKAMA Signal - dars.gov.et
Haleon Prices $2 Billion in Guaranteed Senior Notes Under New Indenture - The Globe and Mail
Haleon (HLN) Watch: Finishes 1.32% Up at $10.00 in the Latest Session; Range View: Support at $9.50 and Resistance at $10.50 Frame the Range under the Current SnapshotNHNL Divergence - dars.gov.et
Haleon (HLN) Watch: Finishes 1.32% Up at $10.00 in the Latest Session; Range View: Support at $9.50 and Resistance at $10.50 Frame the Range under the Current SnapshotLow Vol Factor - www.dars.gov.et
Haleon Prices $2 Billion in Guaranteed Senior Notes Under New Indenture - TipRanks
ACCO vs. HLN: Which Stock Is the Better Value Option? - Eastern Progress
LCUT vs. HLN: Which Stock Is the Better Value Option? - Eastern Progress
Haleon stock benefits from ongoing £500 million buyback as shares trade close to 352p - AD HOC NEWS
Haleon (HLN) Earnings Update: EPS Comes in Above Forecast; Trading Move: Shares End With Little Net Change on the DayEstimate Accuracy - careplusvn.com
Haleon plc (HLN) Finalizes £500 Million Share Buyback After Cancelling 1,569,800 Shares in August 2026 - Kalkine Media
Haleon plc (HLN) Completes Purchase of Nearly 11 Million Shares for Cancellation Under March 2026 Buyback Plan - Kalkine Media
Haleon prices $2bn bond offering across three tranches - Investing.com
Haleon prices $2bn bond offering across three tranches By Investing.com - Investing.com South Africa
Haleon prices $2bn bond offering across three tranches By Investing.com - Investing.com India
Haleon (HLN) Launches $2 Billion Three-Tranche USD Bond to Refinance 2027 Maturities - Kalkine Media
Haleon’s New Gum‑Health Toothpaste Trial: What Investors Should Watch - TipRanks
Haleon (LSE:HLN) Brings Consumer Resilience Into Healthcare Stocks - Kalkine Media
HLN Q4 2024 Earnings: Adjusted EPS Beats Estimates by 7.2% as Consumer Health Demand SteadiesRevenue Miss Report - dars.gov.et
HLN Q4 2024 Earnings: Adjusted EPS Beats Estimates by 7.2% as Consumer Health Demand SteadiesRevenue Guidance Range - careplusvn.com
HLN Q4 2024 Earnings: Adjusted EPS Beats Estimates by 7.2% as Consumer Health Demand Steadies - dars.gov.et
HLN Q4 2024 Earnings: Adjusted EPS Beats Estimates by 7.2% as Consumer Health Demand SteadiesHealthcare Earnings Report - www.dars.gov.et
Haleon (NYSE: HLN) expands shelf to cover guaranteed debt via finance subs - Stock Titan
Haleon unit launches tender offer for $2 billion 2027 notes By Investing.com - Investing.com India
Haleon unit launches tender offer for $2 billion 2027 notes - Investing.com
Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Bank of America Corp DE Acquires 1,586,230 Shares of Haleon PLC Sponsored ADR $HLN - MarketBeat
Haleon plc (HLN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Haleon (LSE:HLN) Offers Consumer Healthcare Exposure - Kalkine Media
Haleon (LSE:HLN) Tests The Blue-Chip Power Of Everyday Health Brands - Kalkine Media
Hikma Pharmaceuticals Names Tobias Hestler, Ex-Haleon CFO, as Independent Non-Executive Director - Kalkine Media
Quantinno Capital Management LP Purchases 128,917 Shares of Haleon PLC Sponsored ADR $HLN - MarketBeat
Haleon Canada Appoints Daniela Cavinatto as General Manager - Finviz
Could Today’s Market Mood Put Haleon (LSE:HLN) Under a Sharper Lens? - Kalkine Media
Sei Investments Co. Grows Stock Position in Haleon PLC Sponsored ADR $HLN - MarketBeat
Haleon Plc Adr Azioni (HLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.29%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):